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A 57-year-old Caucasian female was referred to our 
clinic due to hypertension, flushing, and diarrhea. She 
had a medical history of hypertension and paroxysmal 
atrial fibrillation. On physical examination, the patient 
had a heart rate of 70 bpm and a respiratory rate of 12 
breaths/min. Her temperature was 37°C and her blood 
pressure was 120/80 mmHg. Cardiac examination 
revealed a left parasternal holosystolic murmur, and a 
palpable right ventricular heave. Lung auscultation was 
unremarkable. From the initial biochemical exam she had 
no specific abnormalities. The ECG showed sinus 
rhythm, negative T-waves in leads III, V1-5. The 
transthoracic echocardiography study revealed a left 
ventricle with normal size and normal systolic function 
and dilatation of the left atrium, whereas the right cardiac 
chambers were dilated with thickened, immobile leaflets 
of the tricuspid and pulmonic valve, leading to 
malcoaptation and severe tricuspid and pulmonic 
regurgitation (Fig. 1-5). The clinical and 
echocardiographic findings raised the suspicion of 
carcinoid heart disease. Abdominal computed 
tomography (CT) demonstrated hepatic metastases and 
the patient was treated with chemotherapy and with the 
somatostatin analog octreotide. 
 
  
Figure 1. Right ventricular inflow view in systole showing 
thickened, immobile and retracted anterior and septal leaflets of 
tricuspid valve.  
 
  
Figure 2. Apical four-chamber view: color Doppler 
demonstrates severe tricuspid valve regurgitation.  
 
  
Figure 3. Apical 4-chamber view in systole: opened and 
retracted tricuspid valve (left); mitral valve is closed (right) 
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Figure 4. Short axis view in diastole depicting a fixed and 
immobile pulmonic valve. 
 
 
  
Figure 5. Short axis view in diastole. Color Doppler 
demonstrates severe pulmonic regurgitation.  
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Carcinoid tumors are uncommon malignancies that 
arise from enterochromaffin cells typically located in the 
gastrointestinal tract or lungs.1 These tumors may secrete 
large amounts of vasoactive substances, including 5-
hydroxytryptamine and prostaglandins, which in turn 
cause various clinical manifestations such as flushing, 
diarrhea, and bronchospasm. Carcinoid syndrome occurs 
in <10% of patients and is caused by tumor secretion of 
hormonal mediators (serotonin, somatostatin, gastrin). Its 
manifestations include facial flushing, edema of the head 
and neck, abdominal cramps and diarrhea, 
bronchopspasm, cardiac lesions. Its treatment is resection 
of hepatic metastases, the somatostatin analog octreotide 
and chemotherapy.2 Cardiac lesions are found in 50-60% 
of patients with carcinoid syndrome, usually between 18-
24 months after diagnosis is established.3  Carcinoid heart 
disease results from the layering of plaque-like material 
over the tricuspid valve, right ventricular endocardium 
and pulmonic valve and presents with right heart failure 
and tricuspid and pulmonic regurgitation. Carcinoid 
involvement of the heart is a late manifestation of 
metastatic disease. Cardiac surgery for valve replacement 
remains the mainstay therapy for valvular heart disease 
caused by carcinoid tumors.4,5  
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